Details

Use of conjugate pneumococcal vaccine – 15 valent (PNEU-C-15) and 20 valent (PNEU-C-20) in adults: Summary of NACI Statement of February 2023 - Canada.ca

Metadata and links for an archived snapshot.

Source: Public Health Agency of Canada
Date: Jan 13, 2026 · edition #7
Timestamp: 2026-01-13T00:11:18.774Z
Language: en
Original URL: https://www.canada.ca/en/public-health/services/immunization/national-advisory-committee-on-immunization-naci/public-health-level-recommendations-use-pneumococcal-vaccines-adults-including-use-15-valent-20-valent-conjugate-vaccines/summary-february-2023.html
Replay URL: https://replay.healtharchive.ca/job-7/20260113001118/https://www.canada.ca/en/public-health/services/immunization/national-advisory-committee-on-immunization-naci/public-health-level-recommendations-use-pneumococcal-vaccines-adults-including-use-15-valent-20-valent-conjugate-vaccines/summary-february-2023.html#ha_snapshot=761656
ID: 761656
Status: 200
Type: text/html

Independent archive · Not an official government website. For up-to-date recommendations, always consult the official source website.

Other snapshots